Home
About
Overview
Sharing Data
ORCID
Help
History (1)
IFN-ß treatment requires B cells for efficacy in neuroautoimmunity.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
IFN-ß treatment requires B cells for efficacy in neuroautoimmunity.
IFN-ß treatment requires B cells for efficacy in neuroautoimmunity. J Immunol. 2015 Mar 01; 194(5):2110-6.
View in:
PubMed
subject areas
Animals
Animals
Antigens, CD
Antigens, CD
Autoantibodies
Autoantibodies
Autoimmunity
Autoimmunity
B-Lymphocyte Subsets
B-Lymphocyte Subsets
Brain
Brain
Case-Control Studies
Case-Control Studies
Encephalomyelitis, Autoimmune, Experimental
Encephalomyelitis, Autoimmune, Experimental
Female
Female
Gene Expression Regulation
Gene Expression Regulation
Glatiramer Acetate
Glatiramer Acetate
Humans
Humans
Immunosuppressive Agents
Immunosuppressive Agents
Interferon-beta
Interferon-beta
Interleukin-10
Interleukin-10
Lymphocyte Depletion
Lymphocyte Depletion
Mice
Mice
Mice, Inbred C57BL
Mice, Inbred C57BL
Mice, Transgenic
Mice, Transgenic
Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis, Relapsing-Remitting
Myelin-Oligodendrocyte Glycoprotein
Myelin-Oligodendrocyte Glycoprotein
Peptide Fragments
Peptide Fragments
Peptides
Peptides
Signal Transduction
Signal Transduction
Spleen
Spleen
authors with profiles
Robert Axtell
Gabriel Pardo